A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia. Himonas E, de Beauchamp L, Zerbst D, Desmares-Romain E, et al. Blood 2026 Feb 24:blood.2024027853. doi: 10.1182/blood.2024027853.

Read + Share

Amedeo Smart

Independent Medical Education

Himonas E, de Beauchamp L, Zerbst D, Desmares-Romain E, et al. A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia. Blood 2026 Feb 24:blood.2024027853. doi: 10.1182/blood.2024027853.
PMID: 41734389